Patents by Inventor Michael Inman

Michael Inman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210022647
    Abstract: A stimulation electrode assembly configured to be positioned relative to a patient for an operative procedure is disclosed. An evoked stimulation response may be sensed by a sensor near a portion of a subject. The evoked response may be sensed by an electrode and determined with a monitoring system. The evoked response may additionally and/or alternatively be sensed with a motion sensor. A position sensor may be provided to measure or determine whether the sensor has moved during a procedure.
    Type: Application
    Filed: October 8, 2020
    Publication date: January 28, 2021
    Inventors: Dana Michael Inman, Kevin L. McFarlin, Wenjeng Li
  • Patent number: 10799152
    Abstract: A stimulation electrode assembly configured to be positioned relative to a patient for an operative procedure is disclosed. An evoked stimulation response may be sensed by a sensor near a portion of a subject. The evoked response may be sensed by an electrode and determined with a monitoring system. The evoked response may additionally and/or alternatively be sensed with a motion sensor. A position sensor may be provided to measure or determine whether the sensor has moved during a procedure.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: October 13, 2020
    Assignee: Medtronic Xomed, Inc.
    Inventors: Dana Michael Inman, Kevin L. McFarlin, Wenjeng Li
  • Publication number: 20180042524
    Abstract: A stimulation electrode assembly configured to be positioned relative to a patient for an operative procedure is disclosed. An evoked stimulation response may be sensed by a sensor near a portion of a subject. The evoked response may be sensed by an electrode and determined with a monitoring system. The evoked response may additionally and/or alternatively be sensed with a motion sensor. A position sensor may be provided to measure or determine whether the sensor has moved during a procedure.
    Type: Application
    Filed: August 11, 2016
    Publication date: February 15, 2018
    Inventors: Dana Michael Inman, Kevin L. McFarlin, Wenjeng Li
  • Patent number: 9750429
    Abstract: The present invention relates to the field of ambulatory and non-invasive monitoring of a plurality of physiological parameters of a monitored individual. The invention includes a physiological monitoring apparatus with an improved monitoring apparel, the apparel having sensors for monitoring parameters reflecting pulmonary function and/or parameters reflecting cardiac function and/or parameters reflecting the function of other organ systems. The apparel is preferably also suitable for medical, athletic, and for other uses. The sensors include one or more inductive plethysmographic sensors positioned to monitor at least basic pulmonary parameters, and optionally also basic cardiac parameters. The sensors include one or more ECG sensor electrodes that preferably include a flexible, conductive fabric. The monitoring apparatus also includes an electronic unit for receiving data from the sensors and for storing the data in a computer-readable medium and/or wirelessly transmitted the data.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: September 5, 2017
    Assignee: adidas AG
    Inventors: Marvin A. Sackner, Dana Michael Inman
  • Patent number: 9462975
    Abstract: The present invention relates to the field of ambulatory and non-invasive monitoring of a plurality of physiological parameters of a monitored individual. The invention includes a physiological monitoring apparatus with an improved monitoring apparel, the apparel having sensors for monitoring parameters reflecting pulmonary function and/or parameters reflecting cardiac function and/or parameters reflecting the function of other organ systems. The apparel is preferably also suitable for medical, athletic, and for other uses. The sensors include one or more inductive plethysmographic sensors positioned to monitor at least basic pulmonary parameters, and optionally also basic cardiac parameters. The sensors include one or more ECG sensor electrodes that preferably include a flexible, conductive fabric. The monitoring apparatus also includes an electronic unit for receiving data from the sensors and for storing the data in a computer-readable medium and/or wirelessly transmitted the data.
    Type: Grant
    Filed: December 17, 2010
    Date of Patent: October 11, 2016
    Assignee: adidas AG
    Inventors: Marvin A. Sackner, Dana Michael Inman
  • Patent number: 8790272
    Abstract: A method for determining cardiac parameters of a subject includes receiving a signal from a thoracocardiograph (TCG) sensor. The signal is sensitive to positions and/or motions of an anterior chest wall of the subject and include a cardiac component, a respiratory component, and noise and/or artifact components. The method also includes receiving one or more electrocardiogram (ECG) signals and filtering the received TCG signal to limit one or more of the respiratory component and the noise and/or artifact components. The filtering includes one or more of wavelet de-noising, non-linear filtering, and state space filtering. The method further includes ensemble averaging thefiltered TCG signal. Ensemble members are triggered by occurrence of one or more selected fiducial points determined in the ECG signal. Additionally, the method includes extracting parameters of cardiac functioning from the ensemble averaged signal.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: July 29, 2014
    Assignee: adidas AG
    Inventors: Marvin Sackner, Lance Myers, Desmond B. Keenan, Dana Michael Inman
  • Patent number: 8565881
    Abstract: A method and an apparatus for projecting an end of service (EOS) and/or an elective replacement indication (ERI) of a component in an implantable device is provided. The method comprises measuring the measured voltage of the energy storage device, and determining whether the measured voltage is less than a transition voltage. When the measured voltage is less than the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the measured voltage. When the measured voltage is greater than or equal to the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the total charge depleted. The transition voltage is a voltage associated with the transition point of non-linearity in the battery voltage depletion curve.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: October 22, 2013
    Assignee: Cyberonics, Inc.
    Inventors: Randolph K. Armstrong, Scott A. Armstrong, D. Michael Inman, Timothy L. Scott
  • Patent number: 8560070
    Abstract: A method and an apparatus for determining a time period remaining in a useful life of an energy storage device in an implantable medical device. The method may include measuring a voltage of the energy storage device to produce a measured voltage, and comparing the measured voltage to a transition voltage. While the measured voltage is greater than or equal to the transition voltage, the time period remaining in the energy storage device's useful life is approximated based upon a function of charge depleted. While the measured voltage is less than the transition voltage, the time period remaining in the energy storage device's useful life is approximated based upon a higher order polynomial function of the measured voltage. The transition voltage corresponds to a predetermined point on a energy storage device voltage depletion curve representing the voltage across the energy storage device over time.
    Type: Grant
    Filed: March 17, 2010
    Date of Patent: October 15, 2013
    Assignee: Cyberonics, Inc.
    Inventors: Randolph K. Armstrong, Scott A. Armstrong, D. Michael Inman, Timothy L. Scott
  • Patent number: 8437853
    Abstract: An implantable medical device (IMD) may include a lead circuit including a first node configured to be coupled to a first lead that may be coupled to a first target tissue and including a second node configured to be coupled to a second lead that may be coupled to a second target tissue. The IMD may include an impedance unit that may determine at least one characteristic of coupled energy associated with the lead circuit, where the coupled energy may be produced by a source external to the IMD. The impedance unit may provide an impedance between the first node and the second node, where the impedance is selected based at least in part on a characteristic of the coupled energy. The impedance is selected to reduce the coupled energy or a negative effect associated with functionality of the IMD induced by the coupled energy.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: May 7, 2013
    Assignee: Cyberonics, Inc.
    Inventors: Dana Michael Inman, Randolph K. Armstrong, Scott A. Armstrong
  • Patent number: 8295946
    Abstract: An electrode assembly includes an electrode adapted to at least partially surround a first longitudinal portion of a target nerve or nerve bundle. The electrode includes an inner surface adapted to contact an outer surface of the target nerve or nerve bundle. The electrode also includes a plurality of fiber elements each having a proximal end and a distal end. The fiber elements are coupled at the proximal ends to the inner surface of the electrode and the distal ends of the fiber elements are operative to penetrate the outer surface of the target nerve or nerve bundle.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: October 23, 2012
    Assignee: Cyberonics, Inc.
    Inventor: D. Michael Inman
  • Publication number: 20120130452
    Abstract: An implantable medical device (IMD) may include a lead circuit including a first node configured to be coupled to a first lead that may be coupled to a first target tissue and including a second node configured to be coupled to a second lead that may be coupled to a second target tissue. The IMD may include an impedance unit that may determine at least one characteristic of coupled energy associated with the lead circuit, where the coupled energy may be produced by a source external to the IMD. The impedance unit may provide an impedance between the first node and the second node, where the impedance is selected based at least in part on a characteristic of the coupled energy. The impedance is selected to reduce the coupled energy or a negative effect associated with functionality of the IMD induced by the coupled energy.
    Type: Application
    Filed: January 27, 2012
    Publication date: May 24, 2012
    Applicant: CYBERONICS, INC.
    Inventors: Dana Michael INMAN, Randolph K. ARMSTRONG, Scott A. ARMSTRONG
  • Patent number: 8180462
    Abstract: A method, system, and apparatus are provided for using an electrode for delivering an electrical signal to a first tissue of a patient's body. An electrode system comprises a lead and an electrode coupled to the lead. The electrode includes a stimulation portion that couples to the first tissue to deliver an electrical signal to the first tissue. The electrode also includes a dissipation portion that does not interface with the first tissue. The dissipation portion is adapted to dissipate thermal energy from the electrode.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: May 15, 2012
    Assignee: Cyberonics, Inc.
    Inventors: D. Michael Inman, Jason D. Begnaud
  • Patent number: 8165693
    Abstract: A method, system, and apparatus for implementing a safe mode operation of an implantable medical system using impedance adjustment(s) are provided. A first impedance is provided to a lead. An indication of a possibility of a coupled energy is received. Based upon said indication, a second impedance associated with the lead to reduce the coupled energy is provided.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: April 24, 2012
    Assignee: Cyberonics, Inc.
    Inventors: Dana Michael Inman, Randolph K. Armstrong, Scott A. Armstrong
  • Patent number: 8140159
    Abstract: A method, system, and apparatus for implementing a safe mode operation of an implantable medical system using impedance adjustment(s) are provided. A first impedance is provided to a lead. An indication of a possibility of a coupled energy is received. Based upon said indication, a second impedance associated with the lead to reduce the coupled energy is provided.
    Type: Grant
    Filed: July 21, 2005
    Date of Patent: March 20, 2012
    Assignee: Cyberonics, Inc.
    Inventors: Dana Michael Inman, Randolph K. Armstrong, Scott A. Armstrong
  • Publication number: 20110224767
    Abstract: An electrode assembly includes an electrode adapted to at least partially surround a first longitudinal portion of a target nerve or nerve bundle. The electrode includes an inner surface adapted to contact an outer surface of the target nerve or nerve bundle. The electrode also includes a plurality of fiber elements each having a proximal end and a distal end. The fiber elements are coupled at the proximal ends to the inner surface of the electrode and the distal ends of the fiber elements are operative to penetrate the outer surface of the target nerve or nerve bundle.
    Type: Application
    Filed: May 23, 2011
    Publication date: September 15, 2011
    Applicant: Cyberonics, Inc.
    Inventor: D. Michael Inman
  • Patent number: 7974707
    Abstract: An apparatus and system are provided for employing an electrode for delivering an electrical signal to a portion of a tissue of a patient's body. The electrode includes a first surface to electrically couple to the portion of an outer layer of the tissue. The electrode also includes a plurality of fibers or longitudinal elements coupled to the outer surface. The plurality of fibers or longitudinal elements are adapted to migrate to an interior portion of the tissue.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: July 5, 2011
    Assignee: Cyberonics, Inc.
    Inventor: D. Michael Inman
  • Publication number: 20110087115
    Abstract: The present invention relates to the field of ambulatory and non-invasive monitoring of a plurality of physiological parameters of a monitored individual. The invention includes a physiological monitoring apparatus with an improved monitoring apparel, the apparel having sensors for monitoring parameters reflecting pulmonary function and/or parameters reflecting cardiac function and/or parameters reflecting the function of other organ systems. The apparel is preferably also suitable for medical, athletic, and for other uses. The sensors include one or more inductive plethysmographic sensors positioned to monitor at least basic pulmonary parameters, and optionally also basic cardiac parameters. The sensors include one or more ECG sensor electrodes that preferably include a flexible, conductive fabric. The monitoring apparatus also includes an electronic unit for receiving data from the sensors and for storing the data in a computer-readable medium and/or wirelessly transmitted the data.
    Type: Application
    Filed: December 17, 2010
    Publication date: April 14, 2011
    Applicant: adidas AG
    Inventors: Marvin A. Sackner, Dana Michael Inman
  • Publication number: 20100268495
    Abstract: A method and an apparatus for projecting an end of service (EOS) and/or an elective replacement indication (ERI) of a component in an implantable device is provided. The method comprises measuring the measured voltage of the energy storage device, and determining whether the measured voltage is less than a transition voltage. When the measured voltage is less than the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the measured voltage. When the measured voltage is greater than or equal to the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the total charge depleted. The transition voltage is a voltage associated with the transition point of non-linearity in the battery voltage depletion curve.
    Type: Application
    Filed: June 22, 2010
    Publication date: October 21, 2010
    Applicant: CYBERONICS, INC.
    Inventors: Randolph K. ARMSTRONG, Scott A. ARMSTRONG, D. Michael INMAN, Timothy L. SCOTT
  • Publication number: 20100198313
    Abstract: A method and an apparatus for determining a time period remaining in a useful life of an energy storage device in an implantable medical device. The method may include measuring a voltage of the energy storage device to produce a measured voltage, and comparing the measured voltage to a transition voltage. While the measured voltage is greater than or equal to the transition voltage, the time period remaining in the energy storage device's useful life is approximated based upon a function of charge depleted. While the measured voltage is less than the transition voltage, the time period remaining in the energy storage device's useful life is approximated based upon a higher order polynomial function of the measured voltage. The transition voltage corresponds to a predetermined point on a energy storage device voltage depletion curve representing the voltage across the energy storage device over time.
    Type: Application
    Filed: March 17, 2010
    Publication date: August 5, 2010
    Applicant: CYBERONICS, INC.
    Inventors: Randolph K. ARMSTRONG, Scott A. ARMSTRONG, D. Michael INMAN, Timothy L. SCOTT
  • Patent number: 7769455
    Abstract: A method and an apparatus for projecting an end of service (EOS) and/or an elective replacement indication (ERI) of a component in an implantable device is provided. The method comprises measuring the measured voltage of the energy storage device, and determining whether the measured voltage is less than a transition voltage. When the measured voltage is less than the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the measured voltage. When the measured voltage is greater than or equal to the transition voltage, determining a time period remaining until an end of service of the energy storage device is based upon a function of the total charge depleted. The transition voltage is a voltage associated with the transition point of non-linearity in the battery voltage depletion curve.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: August 3, 2010
    Assignee: Cyberonics, Inc.
    Inventors: Randolph Armstrong, Scott A. Armstrong, Dana Michael Inman, Timothy Scott